Human pathology
Circulating tumour DNA as a prognostic tool for surgically treated pancreatic ductal adenocarcinoma.
Trine Aaquist, Tenna Vesterman Henriksen, Lea Lecanda Mariager Jakobsen, Claus Wilki Fristrup, Per Pfeiffer, Karin de Stricker, Ernesto Sparrelid, Carlos Fernández Moro, Frank Mortensen, Anders Riegels Knudsen, Stephen Hamilton-Dutoit, Jörg Kleeff, Michael Bau Mortensen, Claus Lindbjerg Andersen, Sönke Detlefsen
Published: 202510.1016/j.humpath.2025.106024
Abstract
INTRODUCTION: Pancreatic ductal adenocarcinoma (PDAC) has a high risk of early recurrence after surgery. We evaluated the utility of circulating tumour DNA (ctDNA) analysed at different time points as a prognostic tool. Secondary aims were prognostic…
Preview only. Read the full abstract at the source